Witnesses

Filter Search

Szubin, Adam J. Distinguished Practitioner-in-Residence Johns Hopkins School of Advanced International Studies Of Counsel Sullivan & Cromwell LLP New York, NY

06/19/19 Combating Kleptocracy: Beneficial Ownership, Money Laundering, and Other Reforms

Krumholz, Sheila Executive Director Center for Responsive Politics Washington, DC

06/19/19 Combating Kleptocracy: Beneficial Ownership, Money Laundering, and Other Reforms

06/26/18 Protecting Our Elections: Examining Shell Companies and Virtual Currencies as Avenues for Foreign Interference

Fuller, Clay Jeane Kirkpatrick Fellow, Foreign and Defense Policy Studies American Enterprise Institute Washington, DC

06/19/19 Combating Kleptocracy: Beneficial Ownership, Money Laundering, and Other Reforms

02/06/18 Beneficial Ownership: Fighting Illicit International Financial Networks Through Transparency

Powell, Lynda W. Professor of Political Science University of Rochester Rochester, NY

06/18/19 Keeping Congress Accountable: Term Limits In the United States

Burgat, Casey Senior Fellow, Governance Project R Street Institute Washington, DC

06/18/19 Keeping Congress Accountable: Term Limits In the United States

DeMint, Jim Former U.S. Senator State of South Carolina

06/18/19 Keeping Congress Accountable: Term Limits In the United States

Tomboulides, Nick Executive Director U.S. Term Limits Melbourne, FL

06/18/19 Keeping Congress Accountable: Term Limits In the United States

Raush, Jr., Ph.D., John David Teel Bivins Professor of Political Science West Texas A&M University Canyon, TX

06/18/19 Keeping Congress Accountable: Term Limits In the United States

Garthwaite, Craig Kellogg School of Management Northwestern University Evanston, IL

06/12/19 Your Doctor/Pharmacist/Insurer Will See You Now: Competitive Implications of Vertical Consolidation in the Healthcare Industry

Greaney, Thomas College of the Law UC Hastings San Francisco, CA

06/12/19 Your Doctor/Pharmacist/Insurer Will See You Now: Competitive Implications of Vertical Consolidation in the Healthcare Industry

Scott Morton, Ph.D., Fiona M. Theodore Nierenberg Professor of Economics Yale School of Management New Haven, CT

06/12/19 Your Doctor/Pharmacist/Insurer Will See You Now: Competitive Implications of Vertical Consolidation in the Healthcare Industry

05/21/19 Understanding the Digital Advertising Ecosystem and the Impact of Data Privacy and Competition Policy

Capps, Cory Partner Bates White Economic Consulting Washington, DC

06/12/19 Your Doctor/Pharmacist/Insurer Will See You Now: Competitive Implications of Vertical Consolidation in the Healthcare Industry

Hill, Laurie Vice President, Intellectual Property Genentech San Francisco, CA

06/11/19 The State of Patent Eligibility in America: Part III

Merino, Gonzalo Vice President and Chief Intellectual Property Counsel Regeneron Pharmaceuticals New York, NY

06/11/19 The State of Patent Eligibility in America: Part III

Vandenberg, John D. Partner Klarquist Sparkman, LLP Sherwood, OR

06/11/19 The State of Patent Eligibility in America: Part III

O'Neill, Peter Executive Director Cleveland Clinic Innovations Cleveland, OH

06/11/19 The State of Patent Eligibility in America: Part III

Spetzler, David President and Chief Scientific Officer Caris Life Sciences Irving, TX

06/11/19 The State of Patent Eligibility in America: Part III

Self, Laurie Senior Vice-President and Counsel, Government Affairs Qualcomm Washington, DC

06/11/19 The State of Patent Eligibility in America: Part III

Schecter, Manny Chief Patent Counsel IBM Armonk, NY

06/11/19 The State of Patent Eligibility in America: Part III

Blankstein, Michael Senior Vice President and Deputy General Counsel - Patents and Licensing Scientific Games Las Vegas, NV

06/11/19 The State of Patent Eligibility in America: Part III

Holz, Byron Senior Intellectual Property Rights Licensing Counsel Nokia Snellville, GA

06/11/19 The State of Patent Eligibility in America: Part III

Salsberg, Corey Vice President, Global Head IP Affairs Novartis Washington, DC

06/11/19 The State of Patent Eligibility in America: Part III

George, Sean Chief Executive Officer Invitae San Francisco, CA

06/11/19 The State of Patent Eligibility in America: Part III

Deberadine, Robert Chief Intellectual Property Counsel Johnson & Johnson New Brunswick, NJ

06/11/19 The State of Patent Eligibility in America: Part III

Chotkowski, Kim Vice President, Head of Licensing Strategy and Operations InterDigital Washington, DC

06/11/19 The State of Patent Eligibility in America: Part III

Showing page of 220